Prospective designing and types of buccal drug delivery system: The Review
DOI:
https://doi.org/10.30574/gscbps.2020.12.3.0298Keywords:
Bioadhesive film, Bioavailability, Buccal patchesAbstract
Buccal bioadhesive films, releasing topical drugs in the oral cavity at a slow and predetermined rate, provide distinct advantages over traditional dosage forms for treatment of many diseases. The mucosa of the buccal cavity is the most easily accessible transmucosal site. This fast dissolving drug delivery system (FDDS) is suited for the drugs which undergo high first pass metabolism and is used for improving bioavailability with reducing dosing frequency to mouth plasma peak levels, which in turn minimize adverse/side effects and also make it cost effective This article aims to review the recent Designs of buccal patches and their developments in the buccal adhesive drug delivery systems, & Buccal drug delivery is a promising area for continued research with the aim of systemic delivery of orally inefficient drugs as well as a feasible and attractive alternative for non-invasive delivery of potent peptide and protein drug molecules.
Metrics
References
Shidhaye SS. Mucoadhesive bilayered patches for administration of sumatriptan. AAPS pharm sci tech. 2009; 9(3): 1-13.
Vogler EA. Water and the acute biological response to surfaces. J Biomater Sci Polym. 1999; 10: 1015-1045.
KD Tripathi. In Essentials of Medical Pharmacology. 6th ed. JP Medical Publishers. 2003; 606-607.
Drug Delivery via Dissolving Strips, Drug Discovery & Development. 2007; 10(7): 10.
Pramodkumar TM. Oral transmucosal drug delivery systems. Indian drug. 2004; 41(2): 63-112.
Aungst BJ, Rogers NJ. Site Dependence of Absorption Promoting Actions of Lauretha, Na Salicylate, Na2EDTA, and Aprotinin on Rectal, Nasal, and Buccal Insulin Delivery. Pharm Res. 1988; 5 (5): 305–308.
Edsman K. Pharmaceutical applications of mucoadhesion for the non-oral routes. Journal of Pharmacy & Pharmacology. 2005; 57: 3-19.
Michael JR, Ian GT. Mechanisms, barriers and pathways of oral mucosal drug permeation. Adv Drug Del Rev. 1993; 12: 41-60.
Malke S, Shidhaya S. Desai J. Kadam. Mu V. Co-adhesive Buccal Films International J. of Pediatrics & Neonatology. 2014; 6(5): 1665-1678.
Ceballos A, Cirri M, Maestrelli F, Corti G, Mura P. Influence of formulation and process variable on in vitro release of theophylline from directly-compressed Eudragit matrix tablets. Farmaco. 2005; 60: 913-18.
Ahmed AH, Abdel L. Microparticles Formulation as a Targeting Drug Delivery System. Journal of Nanomedicine Research. 2017; 6(2): 00151.
Juliana S, Ribeiro C, Karen de Oliveira C, Laura Oliveira-N. A mini review on drug delivery through wafer technology. Journal of Advance Research. 2019; 20: 33-41.
Sudhakar Y, Knotsu K, Bandopadhyay AK. Bio adhesive drug delivery – A promising option for orally less efficient drugs. J Control Rel. 2006; 114: 15-40.
Radha Madhavi B, Murthy SN, Prameela Rani A, Dileep KG. Buccal Film Drug Delivery System- An Innovative and Emerging Technology. Molecular Ph. & Org. Process Research. 2013; 1(3): 1-6.
Chinna PR, Chaitanya KS, Madhusudan RY. A review on bioadhesive buccal drug delivery systems: current status of formulation & evaluation method. 2011; 19(6): 385-403.
Sharma, M, Rathore, A, Sharma, S, Sadhu, V, Reddy KR, Kulkarni RV. Recent progress in mucoadhesive polymers for buccal drug delivery applications. Nanomaterials in Diagnostic Tools and Devices. 2020; 1: 213–240.
J.F. Forstner, Intestinal mucins in health and disease. Digestion. 17. 1978; 1: 234–263.
Michael JR, Sevda S. Current status and the future of buccal drug delivery systems Indian Pether. Expert Opin. Drug Deliv. 2008; 5(5): 531-542.
Russell DR, Conway BR, Batchelor HK. Proc Pharma Sci World Congress. 2004; 251.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.